296
Participants
Start Date
June 30, 2012
Primary Completion Date
June 30, 2016
Bevacizumab
1.25 mg bevacizumab administered by monthly interval for six months (6 injections).
Ranibizumab
0.5mg ranibizumab administered by monthly interval for six months (6 injections).
RECRUITING
Academic Medical Center, Dept. Ophthalmology, Amsterdam
Collaborators (1)
Leiden University Medical Center
OTHER
Free University Medical Center
OTHER
Erasmus Medical Center
OTHER
Radboud University Medical Center
OTHER
UMC Utrecht
OTHER
University Medical Center Groningen
OTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER